- Home
- AAON vs EXEL Comparison
AAON vs EXEL Comparison
Compare AAON & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAON | EXEL |
|---|---|---|
| Founded | 1988 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.7B |
| IPO Year | 1995 | 2000 |
Fundamental Metrics
Financial Performance| Metric | AAON | EXEL |
|---|---|---|
| Price | $85.30 | $59.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 21 |
| Target Price | ★ $107.75 | $46.50 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | 1.15 | ★ 1.60 |
| Revenue | ★ $1,442,076,000.00 | $452,477,000.00 |
| Revenue This Year | $21.49 | $13.61 |
| Revenue Next Year | $13.70 | $13.13 |
| P/E Ratio | $74.43 | ★ $36.27 |
| Revenue Growth | ★ 20.11 | N/A |
| 52 Week Low | $73.19 | $33.76 |
| 52 Week High | $150.46 | $59.72 |
Technical Indicators
Market Signals| Indicator | AAON | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 56.58 | 55.06 |
| Support Level | $74.71 | $54.38 |
| Resistance Level | $88.17 | $59.44 |
| Average True Range (ATR) | 3.79 | 1.53 |
| MACD | 1.83 | -0.04 |
| Stochastic Oscillator | 66.03 | 75.68 |
Price Performance
Historical ComparisonAbout AAON AAON Inc.
AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.